Hib booster dose should be deferred until vaccine shortage is over
Interim recommendations issued for Hib vaccine shortage
According to interim recommendations from the CDC on the recent recall of Haemophilus influenzae Type b (Hib)-containing vaccines, PedvaxHIB and Comvax, providers should temporarily defer administering the routine booster that is usually administered at age 12 to 15 monthsexcept for children in high-risk groups. Providers should also track children for whom the booster dose is deferred in order to complete the immunization series when adequate vaccine supply returns. The CDC informed providers to return unused vaccine from the recalled lots according to procedures outlined on the Merck Web site (
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
